Cover
Vol. 15 No. 2 (2025)

Published: December 31, 2025

Pages: 97-117

Articles

Endometriosis-Linked Immune Dysregulation and Its Effect on Assisted Reproductive Technology Outcomes: Insights from IFN-γ and IL-13 Cytokine Profiles

Abstract

Endometriosis is a chronic inflammatory gynecological disease and a leading cause of female infertility, characterized by Th1/Th2 cytokine imbalance. Interleukin-13 (IL-13) and Interferon-gamma (IFN-gamma) are cytokines mediating anti-inflammatory and pro- inflammatory pathways, respectively, and were investigated in this study in infertile women with endometriosis undergoing Intracytoplasmic Sperm Injection (ICSI).To explore the potential impact and prognostic value of Interleukin-13 (IL-13) and Interferon- gamma (IFN-gamma) on ICSI outcome and to confirm their role in endometriosis-related infertility .A prospective case-control study was conducted involving 80 infertile women aged 18-40 years, including (n=40) women laparoscopically confirmed with endometriosis and (n=40) infertile women without endometriosis serving as controls. Both groups enrolled in ICSI cycles, and on the day of oocyte retrieval, serum and follicular fluid were collected; then concentrations of IFN-γ and IL-13 were quantified using enzyme-linked immunosorbent assay (ELISA). Ovarian stimulation characteristics, oocyte maturity, embryo quality, maturation rate, fertilization rate, and pregnancy rate were compared between groups using appropriate statistical analyses to investigate their association with endometriosis and their impact on ICSI outcomes. Elevated IFN-γ and IL-13 levels in both serum and follicular fluid are strongly associated with impaired ovarian response and poor ICSI outcomes in women with endometriosis. These findings suggest that inflammatory cytokine imbalance contributes to reduced oocyte developmental competence and embryo quality. Assessment of IFN-γ and IL-13 may provide clinically valuable biomarkers for predicting ART outcomes and could facilitate individualized therapeutic strategies targeting immune-mediated reproductive dysfunction.

References

  1. Camran R. Nezhat, Tomiko T. Oskotsky, Joshua F. Robinson, Susan J. Fisher, Angie Tsuei, Binya Liu, Juan C. Irwin, Brice Gaudilliere, Marina Sirota, David K. Stevenson & Linda C. Giudice npj Women's Health volume 3, Article number: 8 .
  2. Singh, A. K., Dutta, M., Chattopadhyay, R., Chakravarty, B., & Chaudhury, K. (2020). Correlation of cytokine levels in the follicular fluid with oocyte quality and pregnancy outcome in women undergoing IVF. Reproductive Biology and Endocrinology,18, 89.
  3. Qi Q, Li Y, Chen Z, Luo Z, Zhou T, Zhou J, Zhang Y, Chen S and Wang L (2025) Update on the pathogenesis of endometriosis- related infertility based on contemporary ://doi.org/10.28969/IJEIR.v15.i2.r8.25 http evidence.Front. Endocrinol. 16:1558271. doi: 10.3389/fendo.2025.1558271
  4. Boucher A, Brichant G, Gridelet V, Nisolle M, Ravet S, Timmermans M, Henry L. Implantation Failure in Endometriosis Patients: Etiopathogenesis. J Clin Med. 2022 Sep 13;11(18):5366. doi: 10.3390/jcm11185366. PMID: 36143011.
  5. Anchan, M.M. and Dutta, R., 2025. Reframing Endometriosis: Interplay of NETs, Macrophages, and Lymphocytes at the Crossroads of Disease Progression, Infertility, and Malignant Transformation. American Journal of Reproductive Immunology, 94(5), p.e70179 .
  6. Krygere, L.; Jukna, P.; Jariene, K.; Drejeriene, E.,2024. Diagnostic Potential of Cytokine Biomarkers in Endometriosis: Challenges and Insights. Biomedicines 2024, 12,2867. https://doi.org/10.3390/biomedicines1212286 7
  7. Olteanu, I L., Pușcașu, C., Andrei, C. & Zanfirescu, A., 2026. Hormonal dysregulation and neuroinflammation in endometriosis: convergent druggable pathways. Current Issues in Molecular Biology, 48(5), p.528. doi:10.3390/cimb48050528
  8. Shifon, S., Tyrinova, T., Veretelnikova, T., Pasman, N. & Chernykh, E., 2025. Endometriosis as an immune mediated disease: pathogenetic mechanisms and therapeutic strategies. Frontiers in Immunology, 16, p.1727183. doi:10.3389/fimmu.2025.1727183 .
  9. Eker (2024) Eker, S., Park, Y., Guan, X. & Han, S.J. (2024) ‘N Myc and STAT Interactor is an Endometriosis Suppressor’, International Journal of Molecular Sciences, 25(15), p. 8145. doi:10.3390/ijms25158145.
  10. Yan et al. (2024) Yan, J., Zhou, L., Meng, Y. et al. (2024) ‘Single cell analysis reveals insights into epithelial abnormalities in ovarian endometriosis’, Cell Reports, 43(3), 113716. doi:10.1016/j.celrep.2024.113716. Eker (2024) Yan et al ( . 2024 )
  11. Li, Y., Zhang, X., Peng, M., Zhu, J., Zhai, X., Wei, C., Jiao, H., Wu, Z., Huang, S., Liu, M., Li, W., Yang, W., Miao, K., Xu, Q., Chen, L. and Hu, P. (2025) ‘Benchmarking metabolic RNA labeling techniques for high- throughput single-cell RNA sequencing’, Nature Communications, 16, p. 5952 .
  12. Brodin, T., Hadziosmanovic, N., Berglund, L., Olovsson, M., & Holte, J. (2013). Antimüllerian hormone levels are strongly associated with live-birth rates after assisted reproduction. Journal of Clinical Endocrinology & Metabolism, 98(3), 1107– 1114. https://doi.org/10.1210/jc.2012-3676
  13. Carosso, A.R., Revelli, A., Ruffa, A., et al. (2025) ‘Impact of body fat distribution and ://doi.org/10.28969/IJEIR.v15.i2.r8.25 http insulin sensitivity on in vitro fertilization outcomes: a prospective observational study’, Journal of Clinical Medicine, 14(11), p. 3848. doi:10.3390/jcm14113848 .
  14. Wasfy, M.A., Abdel-Dayem, H.M., Morid, E.M. & Zaiton, M.M. (2024) ‘Impact of Obesity on Fertility and ICSI Outcome’, Middle East Fertility Society Journal, 18(3), pp. 145–156 .
  15. Harada, T., Iwabe, T., & Terakawa, N. (2001). Role of cytokines in endometriosis.Fertility and Sterility,76(5), 973–980. https://doi.org/10.1016/S0015- 0282(01)02811-8
  16. Dai, Y., Ye, Z., Lin, X. & Zhang, S. (2025) ‘Immunopathological insights into endometriosis: from research advances to future treatments’, Seminars in Immunopathology, 47(1), pp. 31–45. doi:10.1007/s00281-025-01058-5
  17. Shifon S, Tyrinova T, Veretelnikova T, Pasman N, Chernykh E. Endometriosis as an immune-mediated disease: pathogenetic mechanisms and therapeutic strategies. Front Immunol. 16:1727183. doi:10.3389/fimmu.2025.1727183 .
  18. Fan, Y., Liu, X., & Zhang, H. (2025). The effect of endometriosis on oocyte quality. Frontiers in Endocrinology, 16,1545432. https://doi.org/10.3389/fendo.2025.1545432 .
  19. Bianchi, P. H., Pereira, R. M., Zanatta, A., Alegretti, J. R., Motta, E. L., & Serafini, P. C. (2020). Prolactin and cortisol levels in women with endometriosis and the impact on IVF outcome. Reproductive Biomedicine Online, 21(2), 233–238. https://doi.org/10.1016/j.rbmo.2010.04.007 .
  20. Arshad, A. H., Abu, M. A., Ahmad, M. F., & Karim, A. K. A. (2022). Comparative analysis of IVF-ICSI outcomes between advanced and early stage of endometriosis stimulated with HMG. Malaysian Journal of Medicine and Health Sciences,18(1),1–8. https://medic.upm.edu.my/upload/dokumen/2 022022815102602_MJMHS_1801_02df
  21. Alborzi, S., et al. (2024) ‘Effect of endometriosis on IVF/ICSI outcomes: a systematic review and meta-analysis’, Biomedicines, 12(3), p. 678. doi:10.3390/biomedicines12030678.
  22. Riemma, G., García-Velasco, J.A., Abrão, M.S., Leone Roberti Maggiore, U., Vignali, M., Solima, E., Ceccaroni, M., Chiantera, V., Moawad, G.N., Laganà, A.S., Agrifoglio, V., de Franciscis, P., Di Donna, M.C., Damato, A., Favilli, A. & Etrusco, A . ( 2025 )
  23. Sikora, J., Mielczarek-Palacz, A., & Kondera-Anasz, Z. (2021). Role of interleukin (IL)-13 in endometriosis. American Journal of Reproductive ://doi.org/10.28969/IJEIR.v15.i2.r8.25 http Immunology, 85(2), e13345. https://doi.org/10.1111/aji.13345 .
  24. Agarwal, A., Aponte-Mellado, A., Premkumar, B. J., Shaman, A., & Gupta, S. (2019). The effects of oxidative stress on female reproduction: A review. Reproductive Biology and Endocrinology, 10, 49. https://doi.org/10.1186/1477-7827-10-49 .
  25. Gogacz, M., Gałczyński, K., Nowakowski, Ł., Krajczy, M., & Sieradzka, A. (2018). The role of IFN-γ in the pathogenesis of endometriosis. Ginekologia Polska, 89(8), 439–443. https://doi.org/10.5603/GP.2018.0074 .
  26. Da Broi, M. G., Malvezzi, H., Paz, C. C., Ferriani, R. A., Navarro, P. A., & Martins, W. P. (2019). Follicular fluid from infertile women with mild/minimal endometriosis may compromise the meiotic spindle of in vitro matured oocyte. Human Reproduction, 34(8), 1537–1548. https://doi.org/10.1093/humrep/dez074
  27. Mo, Y., Li, M., Ye, W., Jiang, Z., Lin, X. & Luo, K., 2026. Targeting the immune network in endometriosis: a comprehensive review of pathogenesis, immunomodulation, and emerging therapies. Pharmaceuticals, 19(7), p.1074. doi:10.3390/ph19071074 .
  28. Zagorianakou, N., Makrydimas, S., Moustakli, E., Oikonomou, E.D., Mitrogiannis, I., Sintou, E. & Makrydimas, G., 2026. Epigenetics, oxidative stress, and the microbiome in endometriosis: toward an integrated mechanistic framework for precision medicine. Journal of Personalized Medicine, 16(6), p.299. doi:10.3390/jpm16060299 .